Management of Female and Functional Urology Patients During the COVID Pandemic.


Journal

European urology focus
ISSN: 2405-4569
Titre abrégé: Eur Urol Focus
Pays: Netherlands
ID NLM: 101665661

Informations de publication

Date de publication:
15 Sep 2020
Historique:
received: 01 05 2020
accepted: 29 05 2020
pubmed: 17 6 2020
medline: 21 8 2020
entrez: 17 6 2020
Statut: ppublish

Résumé

Coronavirus disease 19 (COVID-19) has changed standard urology practice around the world. The situation is affecting not only uro-oncological patients but also patients with benign and disabling conditions who are suffering delays in medical attention that impact their quality of life. To propose, based on expert advice and current evidence where available, a strategy to reorganize female and functional urological (FFU) activity (diagnosis and treatment). The present document is based on a narrative review of the limited data available in the urological literature on SARS-Cov-2 and the experience of FFU experts from several countries around the world. In all the treatment schemes proposed in the literature on the COVID-19 pandemic, FFU surgery is not adequately covered and usually grouped into the category that is not urgent or can be delayed, but in a sustained pandemic scenario there are cases that cannot be delayed that should be considered for surgery as a priority. The aim of this document is to provide a detailed management plan for noninvasive and invasive FFU consultations, investigations, and operations. A classification of FFU surgical activity by indication and urgency is proposed, as well as recommendations adopted from the literature for good surgical practice and by surgical approach in FFU in the COVID-19 era. Functional, benign, and pelvic floor conditions have often been considered suitable for delay in challenging times. The long-term implications of this reduction in functional urology clinical activity are currently unknown. This document will help functional urology departments to reorganize their activity to best serve their patients. Many patients will suffer delays in urology treatment because of COVID-19, with consequent impairment of their physical and psychological health and deterioration of their quality of life. Efforts should be made to minimize the burden for this patient group, without endangering patients and health care workers.

Identifiants

pubmed: 32540267
pii: S2405-4569(20)30158-9
doi: 10.1016/j.euf.2020.05.023
pmc: PMC7292598
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1049-1057

Informations de copyright

Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Références

Turk J Urol. 2020 Apr 14;46(3):169-177
pubmed: 32301692
Patient Saf Surg. 2020 Mar 31;14:8
pubmed: 32288785
Nat Rev Urol. 2020 May;17(5):251-253
pubmed: 32203310
Clin Infect Dis. 2020 Jul 28;71(15):813-817
pubmed: 32241022
Int J Urol. 2010 Nov;17(11):944-9
pubmed: 20880073
Cell Host Microbe. 2020 May 13;27(5):704-709.e2
pubmed: 32259477
J Urol. 2020 Jul;204(1):11-13
pubmed: 32249715
Minerva Urol Nefrol. 2020 Jun;72(3):369-375
pubmed: 32202401
J Med Virol. 2020 Jul;92(7):833-840
pubmed: 32243607
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
World J Clin Cases. 2020 Feb 26;8(4):652-657
pubmed: 32149049
J Urol. 2020 Jul;204(1):9-10
pubmed: 32249681
Eur Urol. 2020 Jun;77(6):663-666
pubmed: 32279903
Eur Urol. 2020 Jun;77(6):667-668
pubmed: 32312544
Eur Urol. 2020 Jul;78(1):e38-e39
pubmed: 32192816
Eur Urol. 2020 Aug;78(2):131-133
pubmed: 32303384
BMJ. 2020 Mar 12;368:m998
pubmed: 32165352
J Minim Invasive Gynecol. 2020 Jul - Aug;27(5):1027-1029
pubmed: 32461146
Chin Med J (Engl). 2020 May 5;133(9):1039-1043
pubmed: 32118639
Eur Urol. 2020 Jul;78(1):21-28
pubmed: 32376137

Auteurs

Luis López-Fando (L)

Bladder Section, Urology Department, Hospital Ramón y Cajal, Madrid, Spain.

Paulina Bueno (P)

Bristol Urological Institute, Southmead Hospital, Bristol, UK.

David Carracedo (D)

Functional, Female and Urodynamic Section, Urology Department, Hospital Rey Juan Carlos, Madrid, Spain.

Marcio Averbeck (M)

Videourodynamics Unit, Neuro-Urology Department, Moinhos de Vento Hospital, Porto Alegre, Brazil.

David M Castro-Díaz (DM)

Urology Department, Complejo Hospitalario Universitario de Canarias, Tenerife, Spain; Department of Surgery, Universidad de La Laguna, Tenerife, Spain.

Emmanuel Chartier-Kastler (E)

Medical School, Sorbonne Université, Academic Hospital Pitié-Salpêtrière, Paris, France.

Francisco Cruz (F)

Hospital São João and Faculty of Medicine of Porto, Porto, Portugal.

Roger Dmochowski (R)

Vanderbilt University Medical Center, Nashville, TN, USA.

Enrico Finazzi-Agrò (E)

Department of Surgical Sciences, University of Rome Tor Vergata, Rome, Italy.

Sakineh Hajebrahimi (S)

Research Center for Evidence Based Medicine, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

John Heesakkers (J)

Department of Urology, Radboudumc, Nijmegen, The Netherlands.

George Kasyan (G)

Urology Department, Moscow State University of Medicine and Dentistry, Spasokukotsky Moscow City Hospital, Moscow, Russia.

Tufan Tarcan (T)

Department of Urology, Marmara University School of Medicine and Department of Urology, Koç University School of Medicine, Istanbul, Turkey.

Benoit Peyronnet (B)

Department of Urology, University of Rennes, Rennes, France.

Mauricio Plata (M)

Department of Urology, Fundación Santa Fe de Bogotá, Universidad de los Andes School of Medicine, Bogotá, Colombia.

Bárbara Padilla-Fernández (B)

Urology Department, Complejo Hospitalario Universitario de Canarias, Tenerife, Spain; Department of Surgery, Universidad de La Laguna, Tenerife, Spain.

Frank Van Der Aa (F)

Urology Department, University Hospitals Leuven, KU Leuven, Leuven, Belgium.

Salvador Arlandis (S)

Functional and Reconstructive Urology Section, Urology Department, La Fe University and Polytechnic Hospital, Valencia, Spain. Electronic address: arlandis_sal@gva.es.

Hashim Hashim (H)

Bristol Urological Institute, Southmead Hospital, Bristol, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH